PACTR202305893513285尚未招募Unknown
Contexts and social groups specific, multistage, adaptable by inductive studies- randomised controlled social experiment of a biomedical research literacy program for clinical trials' participants and their social network at CERMEL and other stakeholders in Gabon
CERME0 个研究点目标入组 195 人开始时间: 2023年5月12日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 195
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13 Year(s) 至 18 Year(s)（—）
- 性别
- All
入选标准
- •Willingness to participate and to invite one to two members of the social networks
- •Signed informed consent
排除标准
- 未提供
研究者
相似试验
已完成
不适用
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGITIS IN THE PEDIATRIC POPULATION.PER-062-20Instituto Quimioterapico S.A.,292
招募中
不适用
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF AMOXICILLIN AND AMBROXOL (AMBROXIL®) VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS.-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-104-20Instituto Quimioterapico S.A.,14
招募中
不适用
MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND CLINICAL TRIAL OF SUPERIORITY IN EFFICACY AND SAFETY OF THE FIXED-DOSE COMBINATION OF CEPHALEXIN AND AMBROXOL (BIOBRONCOL®) VERSUS CEPHALEXIN IN THE TREATMENT OF ACUTE BACTERIAL PHARYNGOTONSILLITIS IN ADULTS-J039 Acute tonsillitis, unspecifiedAcute tonsillitis, unspecifiedJ039PER-103-20Instituto Quimioterapico S.A.,25
进行中（未招募）
不适用
Multicenter, randomized, parallel groups, semi-cross over, open Phase IIIB trial to evaluate treatment compliance for subglossal specific Immunotherapy oral lyophilisate tablets GrazaxR in patients suffering from allergic rhinoconjunctivitis caused by grass pollen - NDEUCTR2006-004820-35-ITALK-ABELLO
进行中（未招募）
1 期
Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg in the treatment of motor fluctuations.Parkinson's Disease (PD)MedDRA version: 20.0Level: HLTClassification code 10034005Term: Parkinson's disease and parkinsonismSystem Organ Class: 100000004852EUCTR2020-002754-24-ITBIAL-Portela & Ca, S.A.100